Satellos Bioscience Inc. (MSLE)
NASDAQ: MSLE · Real-Time Price · USD
9.97
-0.22 (-2.16%)
Aug 21, 2026, 12:04 PM EDT - Market open
Satellos Bioscience Employees
As of December 31, 2025, Satellos Bioscience had 21 total employees, including 18 full-time and 3 part-time employees. The number of employees increased by 4 or 23.53% compared to the previous year.
Employees
21
Change (1Y)
4
Growth (1Y)
23.53%
Revenue / Employee
n/a
Profits / Employee
-$1,648,095
Market Cap
212.72M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 21 | 4 | 23.53% | 18 | 3 |
| Dec 31, 2024 | 17 | 1 | 6.25% | 14 | 3 |
| Dec 31, 2023 | 16 | - | - | 4 | 12 |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| Innate Pharma | 164 |
| Coherus Oncology | 144 |
| Tonix Pharmaceuticals Holding | 142 |
| Voyager Therapeutics | 141 |
| Immunic | 100 |
| Keros Therapeutics | 92 |
| Alpha Cognition | 71 |
MSLE News
- 2 days ago - Satellos Bioscience Slides: Investor presentation - Filings
- 7 days ago - Satellos Reports Second Quarter 2026 Financial Results and Highlights Company Progress - GlobeNewsWire
- 7 days ago - Satellos Bioscience Registration statement: Q2 2026 - Filings
- 7 days ago - Satellos Bioscience Registration statement: Q2 2026 - Filings
- 7 days ago - Satellos Bioscience Earnings release: Q2 2026 - Filings
- 9 days ago - Satellos files $300M mixed securities shelf - TheFly
- 10 days ago - Satellos Bioscience Registration statement: Registration filing - Filings
- 5 weeks ago - Satellos Bioscience DMD Drug Shows Early Promise in 6-Month Study Update - MarketBeat